These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27312791)

  • 1. Identification and characterization of novel ligase I inhibitors.
    Pandey M; Kumar S; Goldsmith G; Srivastava M; Elango S; Shameem M; Bannerjee D; Choudhary B; Karki SS; Raghavan SC
    Mol Carcinog; 2017 Feb; 56(2):550-566. PubMed ID: 27312791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of novel SCR7-based small-molecule inhibitor of DNA end-joining, SCR130 and its relevance in cancer therapeutics.
    Ray U; Raul SK; Gopinatha VK; Ghosh D; Rangappa KS; Mantelingu K; Raghavan SC
    Mol Carcinog; 2020 Jun; 59(6):618-628. PubMed ID: 32189406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCR7 is neither a selective nor a potent inhibitor of human DNA ligase IV.
    Greco GE; Matsumoto Y; Brooks RC; Lu Z; Lieber MR; Tomkinson AE
    DNA Repair (Amst); 2016 Jul; 43():18-23. PubMed ID: 27235626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacophore-based screening and identification of novel human ligase I inhibitors with potential anticancer activity.
    Krishna S; Singh DK; Meena S; Datta D; Siddiqi MI; Banerjee D
    J Chem Inf Model; 2014 Mar; 54(3):781-92. PubMed ID: 24593844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships among DNA ligase inhibitors: Characterization of a selective uncompetitive DNA ligase I inhibitor.
    Howes TRL; Sallmyr A; Brooks R; Greco GE; Jones DE; Matsumoto Y; Tomkinson AE
    DNA Repair (Amst); 2017 Dec; 60():29-39. PubMed ID: 29078112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of human DNA ligase inhibitors that target cellular DNA replication and repair.
    Chen X; Zhong S; Zhu X; Dziegielewska B; Ellenberger T; Wilson GM; MacKerell AD; Tomkinson AE
    Cancer Res; 2008 May; 68(9):3169-77. PubMed ID: 18451142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the targeting of human DNA ligase I as a potential new strategy for cancer treatment.
    Saquib M; Ansari MI; Johnson CR; Khatoon S; Kamil Hussain M; Coop A
    Eur J Med Chem; 2019 Nov; 182():111657. PubMed ID: 31499361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of DNA double strand break repair and chromosome aberration formation.
    Iliakis G; Wang H; Perrault AR; Boecker W; Rosidi B; Windhofer F; Wu W; Guan J; Terzoudi G; Pantelias G
    Cytogenet Genome Res; 2004; 104(1-4):14-20. PubMed ID: 15162010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered DNA ligase activity in human disease.
    Tomkinson AE; Naila T; Khattri Bhandari S
    Mutagenesis; 2020 Feb; 35(1):51-60. PubMed ID: 31630206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-Based Virtual Ligand Screening on the XRCC4/DNA Ligase IV Interface.
    Menchon G; Bombarde O; Trivedi M; Négrel A; Inard C; Giudetti B; Baltas M; Milon A; Modesti M; Czaplicki G; Calsou P
    Sci Rep; 2016 Mar; 6():22878. PubMed ID: 26964677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Benzocoumarin-Stilbene Hybrid as a DNA ligase I inhibitor with in vitro and in vivo anti-tumor activity in breast cancer models.
    Hussain MK; Singh DK; Singh A; Asad M; Ansari MI; Shameem M; Krishna S; Valicherla GR; Makadia V; Meena S; Deshmukh AL; Gayen JR; Imran Siddiqi M; Datta D; Hajela K; Banerjee D
    Sci Rep; 2017 Sep; 7(1):10715. PubMed ID: 28878282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-Terminal region of DNA ligase IV drives XRCC4/DNA ligase IV complex to chromatin.
    Liu S; Liu X; Kamdar RP; Wanotayan R; Sharma MK; Adachi N; Matsumoto Y
    Biochem Biophys Res Commun; 2013 Sep; 439(2):173-8. PubMed ID: 23994631
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Roth BM; Varney KM; Yang H; Weber DJ; Tomkinson AE
    Biomol NMR Assign; 2019 Oct; 13(2):305-308. PubMed ID: 31093909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel small molecule inhibitor of the DNA repair protein Ku70/80.
    Weterings E; Gallegos AC; Dominick LN; Cooke LS; Bartels TN; Vagner J; Matsunaga TO; Mahadevan D
    DNA Repair (Amst); 2016 Jul; 43():98-106. PubMed ID: 27130816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual screening and biological evaluation of novel small molecular inhibitors against protein arginine methyltransferase 1 (PRMT1).
    Xie Y; Zhou R; Lian F; Liu Y; Chen L; Shi Z; Zhang N; Zheng M; Shen B; Jiang H; Liang Z; Luo C
    Org Biomol Chem; 2014 Dec; 12(47):9665-73. PubMed ID: 25348815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a specific inhibitor for DNA ligase I in human cells.
    Yang SW; Becker FF; Chan JY
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2227-31. PubMed ID: 1549587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative Okazaki Fragment Ligation Pathway by DNA Ligase III.
    Arakawa H; Iliakis G
    Genes (Basel); 2015 Jun; 6(2):385-98. PubMed ID: 26110316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian DNA ligases.
    Tomkinson AE; Levin DS
    Bioessays; 1997 Oct; 19(10):893-901. PubMed ID: 9363683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways.
    Wang M; Wu W; Wu W; Rosidi B; Zhang L; Wang H; Iliakis G
    Nucleic Acids Res; 2006; 34(21):6170-82. PubMed ID: 17088286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analyses of single-stranded break repair by human DNA ligase III isoforms reveal biochemical differences from DNA ligase I.
    McNally JR; O'Brien PJ
    J Biol Chem; 2017 Sep; 292(38):15870-15879. PubMed ID: 28751376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.